Agilent Beam Enhancer Technology for High-Speed Transmission Raman Spectroscopy

Importance of the Topic

Transmission Raman spectroscopy enables rapid, non-destructive analysis of whole tablets and capsules, critical for ensuring content uniformity and regulatory compliance in pharmaceutical manufacturing. Current throughput limitations and strict regulatory requirements demand faster measurement techniques without compromising sample integrity or safety.

Study Objectives and Overview

This study evaluates the performance of Agilent’s beam enhancer technology integrated into the TRS100 Raman system. The primary goal is to demonstrate over 10× increase in measurement speed for determining active pharmaceutical ingredient (API) concentrations in tablets, without increasing laser power.

Methodology

Tablets containing three APIs and two excipients across concentrations from 0.4 to 89% w/w were analyzed. Transmission Raman spectra were acquired at scan times of 10, 1, 0.1, and 0.01 seconds, both with and without the beam enhancer. Partial least squares calibration models assessed prediction accuracy via root mean square error of cross validation (RMSECV).

Used Instrumentation

Agilent TRS100 Transmission Raman Spectrometer equipped with a removable beam enhancer tray. The beam enhancer recycles reflected laser photons and Raman signal back into the sample to boost emerging photon intensity without increasing excitation power.

Main Findings and Discussion

Integration of the beam enhancer resulted in approximately 10× signal enhancement and a 5× improvement in signal-to-noise ratio across all scan times. PLS models showed significant RMSECV reduction, particularly at faster acquisition speeds. Optimal RMSECV improvement occurred at 0.1 seconds for most analytes and as low as 0.01 seconds for caffeine, highlighting the benefit for high-throughput screening.

Benefits and Practical Applications

• Enables rapid, non-destructive content uniformity testing for thousands of tablets per batch.
• Improves analytical throughput without increasing laser power or sample handling complexity.
• Enhances analysis of low-concentration or weakly scattering components.
• Offers selective surface enhancement, beneficial for coating and thin-layer investigations.

Future Trends and Applications

Advancements in beam enhancer design may further reduce scan times and expand applicability to diverse pharmaceutical forms, including coated and multicomponent tablets. Integration with inline manufacturing processes promises real-time quality control. Continued development of chemometric models will support deeper formulation insights and process optimization.

Conclusion

Agilent’s beam enhancer technology substantially accelerates Transmission Raman spectroscopy for pharmaceutical content uniformity testing, delivering over 10× speed improvements while maintaining or enhancing data quality. This innovation can transform high-volume analytical workflows and strengthen quality assurance protocols.

Reference

1. R. Lostritto. Content Uniformity Testing for the 21st Century, FDA.
2. P. Matousek. Applied Spectroscopy 2007;61:845.
3. J. A. Griffen, A. W. Owen, P. Matousek. Analyst 2015;140:107–112.
4. Y. Zhang, G. M. McGeorge. Journal of Pharmaceutical Innovation 2015;10:269–280.